China’s first COVID-19 mRNA vaccine approved for clinical trials
This is the first COVID-19 mRNA vaccine to be approved for clinical trials in China.
heir study shows that the COVID-19 mRNA vaccine not only induced high levels of neutralizing antibodies in mice and crab-eating macaques, but also induced protective T cell immune responses.
The experiment on crab-eating macaques shows that vaccine-immunized animals can withstand the attack of novel coronavirus, effectively prevent virus replication and pulmonary disease progression, which shows good protective effects.
